Kobayashi Pharma stock launches a four-scent Sawaday gel

Published on 10/08/2026 at 09:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kobayashi Pharma stock was last at JPY 7,206 on October 8, 2026, only 0.24 percent below its 52-week high. First-half revenue rose 2.5 percent.

Kobayashi Pharma, JP3301100008, Illustration mit AI erstellt.

Kobayashi Pharma (ISIN JP3301100008) stock was last at JPY 7,206 on the TSE at 3:30 p.m. JST on October 8, 2026, up 0.74 percent from the previous close. The company launched a redesigned four-scent Sawaday Fragrance Gel in Japan on the same date, according to Kobayashi Pharmaceutical.

New product meets a tougher backdrop

The gel is marketed for rooms and toilets, comes in four scents and uses a compact 140-gram format. The launch gives the household and personal care group a fresh product event, but its financial importance depends on whether new products can offset pressure in the core business.

In the first half of fiscal 2026, revenue rose 2.5 percent year over year to JPY 70.7 billion, while operating profit fell 67.5 percent to JPY 2.1 billion, 36Kr reported on October 8, 2026. The contrast between sales growth and profit contraction makes cost control more important than headline revenue growth.

Buyout proposal remains the larger catalyst

The product launch follows a more consequential corporate development. On September 25, 2026, The Japan Times reported that CVC Capital Partners and Nippon Sangyo Suishin Kiko were weighing a preliminary, nonbinding proposal valued at more than JPY 500 billion to take Kobayashi private.

The market capitalization stood at JPY 535.7 billion on October 8, 2026. That figure puts the reported proposal size in the same broad valuation frame as the listed equity, although the article described the offer as preliminary rather than a fixed tender price.

Stock stays near its yearly high

Kobayashi Pharma stock was 0.24 percent below its 52-week high of JPY 7,223 and 43.3 percent above its 52-week low of JPY 5,030 on October 8, 2026. Trading volume reached 274,100 shares, while the stock's market capitalization was JPY 535.7 billion.

Analyst expectations remain more cautious than the market price. Eulerpool lists a Hold consensus from 12 analysts, with an average target of JPY 5,279.96 and a median target of JPY 5,314.20.

Trading level and investor tension

Kobayashi Pharmaceutical Co., Ltd. is listed under ticker 4967 on the TSE in JPY, according to 6ix. The stock's position near the yearly high reflects the buyout speculation, while the weak operating-profit trend leaves execution and deal terms as the key variables for valuation.